Ad blocking detected

Thank you for visiting CanadianInsider.com. We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads
JOIN THE CLUB

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Pharmadrug Inc. (C:BUZZ)

Business Focus: Pharmaceuticals Wholesale

Sector:  Healthcare Industry:  Pharmaceuticals
 
See Regulatory Filings on SEDAR
Company Contact
Address: 2905 - 77 King Street West
TORONTO ON M5K 1H1
Tel: N/A
Website: https://pharmadrug.ca
IR: See website
Key People
N/A    
Business Overview
Pharmadrug Inc. is a Canada-based specialty pharmaceutical company, which is focused on the research, development and commercialization of controlled substances and medicines such as psychedelics, cannabis and naturally derived approved drugs. The Company operates through three divisions: Pharmadrug Production GmbH (Pharmadrug Production), Interrobang Ltd. (Interrobang), and Sairiyo Therapeutics Inc. (Sairiyo). Pharmadrug Production is a German medical cannabis distribution company, which imports and distributes Bedrocan cannabis from the Netherlands. Interrobang are licensed retailers in the Netherlands that are legally allowed to sell psilocybin bearing truffles. Interrobang is building a vertically integrated retail business with the goal to elevate the use of functional mushrooms, and psilocybin mushrooms. Sairiyo is a biotechnology company focused on repurposing and developing improved formulations of naturally derived compounds for serious, rare, and life-threatening diseases.
Financial Overview
For the fiscal year ended 31 December 2021, Pharmadrug Inc revenues decreased 28% to C$495K. Net loss remained flat at C$5.6M. Revenues reflect a decrease in demand for the Company's products and services due to unfavorable market conditions. Net income reflects Unidentifiable assets acquired decrease from C$4.5M (expense) to C$0K, G/L on Invest HFS, Maturity & Trading increase from C$43K (expense) to C$903K (income).
Reporting Currency: Canadian Dollars
Enterprise value: $13.20M as of Dec 31, 2021
Annual revenue (TTM): $0.50M as of Dec 31, 2021
EBITDA (TTM): -$3.84M as of Dec 31, 2021
Net annual income (TTM): -$5.63M as of Dec 31, 2021
Free cash flow (TTM): -$4.16M as of Dec 31, 2021
Net Debt Last Fiscal Year: N/A
Shares outstanding: 340,816,383 as of Dec 31, 2021
TTM: Trailing Twelve Months
EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization